📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis. (2018)

First Author: Williams AJ

Attributed to: PTH nasal delivery for the treatment of osteoporosis - TSB NINTTO funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ijpharm.2017.10.029

PubMed Identifier: 29038066

Publication URI: http://europepmc.org/abstract/MED/29038066

Type: Journal Article/Review

Volume: 535

Parent Publication: International journal of pharmaceutics

Issue: 1-2

ISSN: 0378-5173